Medtronic CEO: Growth Will Be Driven By Innovation, Globalization, Value-Based Care
Monday, July 25, 2016
Source: Med Device Online
Medtronic wants to generate $40 billion in free-cash-flow (FCF) by 2021, senior leadership said during a recent Investor Day event in New York City. The company’s strategies for future growth include therapy innovation, globalization, and a leadership position in value-based healthcare.
Recent developments at Medtronic— such as itsacquisition of Covidien and subsequent relocation to Ireland — have put the company in a “unique position to drive consistent revenue growth,” chairman and CEO Omar Ishrak told investors, by allowing the company to capitalize on its “robust innovation pipeline, geographic reach, and innovative new healthcare business models.”